¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"allergic death"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • crib death
    ¿ä¶÷»ç
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • cause of death
    »çÀÎ
  • cell death
    ¼¼Æ÷»ç
  • cerebral death
    ´ë³ú»ç
  • child death rate
    ¼Ò¾Æ»ç¸Á·ü
  • death
    »ç¸Á, Á×À½, »ç, »ç¸ê
  • death certificate
    »ç¸ÁÁø´Ü¼­
  • death instinct
    Á×À½º»´É
  • death phase
    »ç¸ê±â
  • death rate
    »ç¸Á·ü
  • death registration area
    »ç¸Áµî·ÏÁö¿ª
  • early fetal death
    Á¶±âžƻç¸Á
  • fetal death
    žƻç¸Á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cerebral death
    (¢¡brain death) ³ú»ç
  • child death rate
    À¯¾Æ»ç¸Á·ü
  • coronary death
    ½ÉÀ嵿¸Æ»ç
  • corrected death rate
    Á¤Á¤»ç¸Á·ü
  • crib death
    ħ´ë»ç, ¿µ¾Æµ¹¿¬»ç
  • crude death rate
    º¸Åë»ç¸Á·ü, Á¶»ç¸Á·ü
  • cumulative death rate
    ´©Àû»ç¸Á·ü
  • death certificate
    »ç¸ÁÁø´Ü¼­
  • death
    »ç¸Á, Á×À½, »ç
  • death instinct
    Á×À½º»´É
  • death phase
    »ç¸ê±â
  • death rate
    »ç¸Á·ü
  • early fetal death
    Á¶±âžƻç¸Á
  • fetal death
    (¢¡intrauterine death) Àڱó»Å¾ƻç¸Á
  • functional death
    ±â´ÉÀû»ç¸Á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • allergic bronchopulmonary
    ¾Ë·¹¸£±â¼º ±â°üÁöÆó(¡­ Ѩηò¨øË)
  • allergic bronchopulmonary aspergillosis
    ¾Ë·¹¸£±â¼º ±â°üÁö Æó ¾Æ½ºÆä¸£±æ·ç½ºÁõ.
  • allergic bronchopulmonary aspergillosis
    ¾Ë·¹¸£±â¼º ±â°üÁö Æó ¾Æ½ºÆä¸£±æ·ç½ºÁõ(¡­àõ Ѩηò¨ øË ¡­ñø)
  • allergic cheilitis
    ¾Ë·¹¸£±â(¼º) ±¸¼ø¿°(¡­Ï¢âîæú).
  • allergic conjunctivitis
    ¾Ë·¹¸£±â°á¸·¿°(¡­Ì¿Ø¯æú).
  • allergic constitution
    ¾Ë·¹¸£±â(¼º) üÁú(¡­ô÷òõ).
  • allergic contact dermatitis
    ¾Ë·¹¸£±â Á¢ÃËÇǺο°( ïÈõºù«Ý±æú)
  • allergic coryza
    ¾Ë·¹¸£±â(¼º) ºñ¿°
  • allergic dermatitis
    ¾Ë·¹¸£±â¼º ÇǺο°(¡­ù«Ý±æú)
  • allergic diarrhea
    ¾Ë·¹¸£±â¼º ¼³»ç.
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ.
  • allergic disorder
    ¾Ë·¹¸£±â(¼º) Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • allergic extract
    ¾Ë·¹¸£±â¼º ÃßÃâ¹°.
  • allergic interstitial pneumonitis
    ¾Ë·¹¸£±â¼º °£Áú¼º Æó·Å(¡­ÊàòõàõøËæú).
  • allergic keratitis
    ¾Ë·¹¸£±â°¢¸·¿° (ÊÇØ¯æú).
  • allergic otitis media
    ¾Ë·¹¸£±â(¼º) ÁßÀÌ¿° (¡­ñéì¼æú).
  • allergic otitis media
    ¾Ë·¹¸£±â(¼º) ÁßÀÌ¿°
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • allergic reaction
    ¾Ë·¹¸£±â(¼º) ¹ÝÀÀ.
  • allergic reaction
    ¾Ë·¹¸£±â(¼º) ¹ÝÀÀ.
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic response
    ¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
  • allergic rhinitis
    ¾Ë·¹¸£±â(¼º) ºñ¿°
  • allergic rhinitis
    ¾Ë·¹¸£±â¼ººñ¿°(¡­Þ¬æú)
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
  • allergic skin disease
    ¾Ë·¹¸£±â[¼º] ÇǺκ´
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ(ÊÙË×̬).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AAG 3-alkaladenine deoxyribonucleic acid glycosylase; allergic angiitis and granulomatosis; alpha-1-acid...
ABA abscissic acid; allergic bronchopulmonary aspergillosis; American Board of Anesthesiologists; antiba...
ABPA actin-binding protein, autosomal form; allergic bronchopulmonary aspergillosis
ACD absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom...
AECD allergic eczematous contact dermatitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EAO Experimental allergic orchitis
E.A.A. Extrinsic Allergic Alveolitis
SAC Seasonal allergic conjunctivitis
SAR Seasonal allergic rhinitis
PAR perennial allergic rhinitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • immediate death
    Áï»ç, ¼ø°£»ç
  • manner of death
    »ç¸ÁÀÇ Á¾·ù
  • maternal death rate
    ¸ð¼º »ç¸Á·ü
  • molecular death
    ºÐÀÚ »ç
  • neocortical death
    ½Å ÇÇÁú»ç
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • organ death
    Àå±â »ç¸Á
  • postoperative death
    ¼úÈÄ »ç
  • sudden infant death syndrome
    ¿µ¾Æ ±Þ»ç ÁõÈıº
  • time of death
    »ç¸Á ½Ã°¢
  • tissue death
    Á¶Á÷»ç
    Á¶Á÷ÀÇ ±«»ç ȤÀº ¼¼Æ÷»ç.
  • violent death
    ¿ÜÀλç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
neuritis, experimental allergic An autoimmune demyelinating disorder of peripheral nerves produced by injection of peripheral nerve tissue protein.
(12 Dec 1998)
dermatitis, allergic contact A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.
(12 Dec 1998)
encephalomyelitis, allergic An experimental demyelinating disease produced in animals by injections of myelin fractions in order to study the relationship between hypersensitivity and the demyelinating diseases.
(12 Dec 1998)
experimental allergic encephalitis <pathology> An autoimmune disease that can be induced in various experimental animals by the injection of homogenised brain or spinal cord in Freund's adjuvant. The antigen appears to be a basic protein present in myelin and the response is characterised by focal areas of lymphocyte and macrophage infiltration into the brain, associated with demyelination and destruction of the blood-brain barrier. Sometimes used as a model for demyelinating diseases, although whether this is entirely justifiable is not clear.
(18 Nov 1997)
experimental allergic encephalomyelitis <pathology> An autoimmune disease that can be induced in various experimental animals by the injection of homogenised brain or spinal cord in Freund's adjuvant. The antigen appears to be a basic protein present in myelin and the response is characterised by focal areas of lymphocyte and macrophage infiltration into the brain, associated with demyelination and destruction of the blood-brain barrier. Sometimes used as a model for demyelinating diseases, although whether this is entirely justifiable is not clear.
(18 Nov 1997)
extrinsic allergic alveolitis <radiology> Exposure to organic dust less than 5u in size, recurrent episodes of fever, chills, dry cough, dyspnea following exposure after 6 hr interval (10-40% assymptomatic), spontaneous resolution in 1-2 days, farmer's lung, Pandora's pneumonitis, bird-fancier's lung, mushroom worker's lung, bagassosis, malt worker's lung, maple bark disease, suberosis, sequoiosis see: acute extrinsic allergic alveolitis, hypersensitivity pneumonitis
(12 Dec 1998)
attitude to death Conceptual response of the individual to the various aspects of death, which are based on his psychosocial and cultural experience.
(12 Dec 1998)
Black Death <disease, organism> Yersinina pestis is a gram-negative, rod-shaped, faculatively anaerobic bacterial species in the family Enterobacteriaceae.
It causes bubonic plaque, which is transmitted by rodent fleas. Historically known as the Black Plague, this disease devastated Europe and Asia in the 1300s.
It still exists today and is characterised by sudden high fever, chills, excessively swollen and tender lymph nodes (buboes), followed by tissue bleeding and gangrene. Other complications include pneumonia and septicaemia.
(12 Nov 1997)
brain death Total cessation of brain function for 24 hours as manifested by absence of spontaneous movement, absence of spontaneous respiration, and absence of all brainstem reflexes.
(12 Dec 1998)
rate, death The number of deaths in the population divided by the average population (or the population at midyear) is the crude death rate. In 1994, for example, the crude death rate per 1,000 population was 8.8 in the united states, 7.1 in Australia, etc. A death rate can also be tabulated according to age or cause.
(12 Dec 1998)
genetic death Death of the bearer of a gene at any age before generating living offspring. May be compatible with good health and long life.
See: genetic lethal.
(05 Mar 2000)
maternal death Death of a woman while pregnant or within 42 days after the termination of gestation, irrespective of the duration and site of pregnancy and the cause of death; two periods are recognised in the 42-day interval: period 1 includes day 1 to day 7; period 2 includes day 8 to day 42. Maternal death's are further classified as:
(05 Mar 2000)
maternal death rate The number of maternal deaths that occur as the direct result of the reproductive process per 100,000 live births.
See: rate.
See: maternal death.
(05 Mar 2000)
cause of death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
(12 Dec 1998)
cell death <cell biology> Cells die (nonaccidentally) either when they have completed a fixed number of division cycles (around 60, the Hayflick limit) or at some earlier stage when programmed to do so, as in digit separation in vertebrate limb morphogenesis.
Whether this is due to an accumulation of errors or a programmed limit is unclear, some transformed cells have undoubtedly escaped the limit.
See: apoptosis.
(26 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • death sand
    Á×À½ÀÇ Àç(radioactive dust)
  • death sentence
    »çÇü ¼±°í
  • death squad
    (Áß³²¹ÌµîÀÇ ±º»çÁ¤±Ç¿¡¼­ÀÇ °æ¹üÁËÀÚ,ÁÂÆÄ µî¿¡ ´ëÇÑ)¾Ï»ì´ë
  • death tax
    (¹Ì)»ó¼Ó¼¼
  • death throes
    Á×À½ÀÇ °íÅë
  • death toll
    »ç¸ÁÀÚ ¼ö
  • death warrant
    »çÇü ÁýÇà ¸í·É
  • death wish
    (½É)Á×°í ½ÍÀº »ý°¢;³²ÀÌ Á×¾úÀ¸¸é ÇÏ´Â ¸¶À½;ȯ°¢Á¦
  • dowry death
    (Àεµ)ÁöÂü±Ý»ìÀÎ(ÁöÂü±Ý ÁöºÒ ºÒÀÌÇàÀ» ÀÌÀ¯·Î ½ÅºÎ¸¦ Á×ÀÓ)
  • natural death
    (³ë¼è¿¡ µû¸¥)ÀÚ¿¬»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á